BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33154164)

  • 1. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
    Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J
    J Biol Chem; 2021; 296():100032. PubMed ID: 33154164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
    Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
    Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
    Sorrentino V; Zelcer N
    Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL).
    Sorrentino V; Scheer L; Santos A; Reits E; Bleijlevens B; Zelcer N
    J Biol Chem; 2011 Aug; 286(34):30190-9. PubMed ID: 21734303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of the LDL receptor-interacting FERM domain in the E3 ubiquitin ligase IDOL reveals an obscured substrate-binding site.
    Martinelli L; Adamopoulos A; Johansson P; Wan PT; Gunnarsson J; Guo H; Boyd H; Zelcer N; Sixma TK
    J Biol Chem; 2020 Sep; 295(39):13570-13583. PubMed ID: 32727844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.
    Sorrentino V; Nelson JK; Maspero E; Marques ARA; Scheer L; Polo S; Zelcer N
    J Lipid Res; 2013 Aug; 54(8):2174-2184. PubMed ID: 23733886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.
    Scotti E; Calamai M; Goulbourne CN; Zhang L; Hong C; Lin RR; Choi J; Pilch PF; Fong LG; Zou P; Ting AY; Pavone FS; Young SG; Tontonoz P
    Mol Cell Biol; 2013 Apr; 33(8):1503-14. PubMed ID: 23382078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia.
    Zhang CP; Tian Y; Zhang M; Tuo QH; Chen JX; Liao DF
    Med Hypotheses; 2016 Jan; 86():138-42. PubMed ID: 26601593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists.
    Scotti E; Hong C; Yoshinaga Y; Tu Y; Hu Y; Zelcer N; Boyadjian R; de Jong PJ; Young SG; Fong LG; Tontonoz P
    Mol Cell Biol; 2011 May; 31(9):1885-93. PubMed ID: 21343340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2.
    Hong C; Duit S; Jalonen P; Out R; Scheer L; Sorrentino V; Boyadjian R; Rodenburg KW; Foley E; Korhonen L; Lindholm D; Nimpf J; van Berkel TJ; Tontonoz P; Zelcer N
    J Biol Chem; 2010 Jun; 285(26):19720-6. PubMed ID: 20427281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
    Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
    J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-21 (FGF21) regulates low-density lipoprotein receptor (LDLR) levels in cells via the E3-ubiquitin ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting saposin-like protein (Msap).
    Do HT; Tselykh TV; Mäkelä J; Ho TH; Olkkonen VM; Bornhauser BC; Korhonen L; Zelcer N; Lindholm D
    J Biol Chem; 2012 Apr; 287(16):12602-11. PubMed ID: 22378787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
    Zhang L; Reue K; Fong LG; Young SG; Tontonoz P
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2541-6. PubMed ID: 22936343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
    Zelcer N; Hong C; Boyadjian R; Tontonoz P
    Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.
    Ibrahim S; Somanathan S; Billheimer J; Wilson JM; Rader DJ
    Cardiovasc Res; 2016 May; 110(1):23-9. PubMed ID: 26786161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.
    Zhang L; Fairall L; Goult BT; Calkin AC; Hong C; Millard CJ; Tontonoz P; Schwabe JW
    Genes Dev; 2011 Jun; 25(12):1262-74. PubMed ID: 21685362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ubiquitin ligase inducible degrader of the LDL receptor/myosin light chain interacting protein in health and disease.
    van Loon NM; Lindholm D; Zelcer N
    Curr Opin Lipidol; 2019 Jun; 30(3):192-197. PubMed ID: 30896554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.
    Calkin AC; Goult BT; Zhang L; Fairall L; Hong C; Schwabe JW; Tontonoz P
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20107-12. PubMed ID: 22109552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDOL G51S Variant Is Associated With High Blood Cholesterol and Increases Low-Density Lipoprotein Receptor Degradation.
    Adi D; Lu XY; Fu ZY; Wei J; Baituola G; Meng YJ; Zhou YX; Hu A; Wang JK; Lu XF; Wang Y; Song BL; Ma YT; Luo J
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2468-2479. PubMed ID: 31597442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
    Sun XX; Chen Y; Su Y; Wang X; Chauhan KM; Liang J; Daniel CJ; Sears RC; Dai MS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):10983-10988. PubMed ID: 30305424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.